(object) array( 'id' => '962326', 'url' => 'IT/fusional_language', 'image' => '', 'title' => 'lingua fusiva', 'tags' => array ( 0 => 'lingua fusiva', 1 => 'Language', 2 => 'Grammar', 3 => '', ), 'term' => 'lingua fusiva', 'source_id' => 791751, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Grammar', ), 'lastedit' => '20110405155610', 'part_of_speech' => 'adjective', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Fusional languages are those in which the divisions between morphemes tend to be difficult to identify and individual affixes tend to have complex meanings. Spanish, like many other European languages, is fusional. For example, in the word "hablan" \'they speak\', linguists differ as to whether "an" is a single suffix with the complex meaning \'third person plural indicative present\', or two suffixes ("-a" \'indicative present\' plus "-n" \'third person plural\'); other analyses are also possible. Fusional languages are similar to agglutinative languages, in that they allow more than one morpheme per word, although usually not as many per word and the morphemes appear to have been squeezed more tightly together.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601654857990146, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'fusional language', 'Definition' => 'Fusional languages are those in which the divisions between morphemes tend to be difficult to identify and individual affixes tend to have complex meanings. Spanish, like many other European languages, is fusional. For example, in the word "hablan" \'they speak\', linguists differ as to whether "an" is a single suffix with the complex meaning \'third person plural indicative present\', or two suffixes ("-a" \'indicative present\' plus "-n" \'third person plural\'); other analyses are also possible. Fusional languages are similar to agglutinative languages, in that they allow more than one morpheme per word, although usually not as many per word and the morphemes appear to have been squeezed more tightly together.', 'Domain' => 'Documentation', 'Industry' => 'Language', 'Part of Speech' => 'adjective', 'Product Category' => 'Grammar', 'Usage Status' => 'New', 'Creation User' => 'CarmenChavarri', 'Creation Date' => '2011/2/23', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'fusional_language', )

(object) array( 'id' => '958774', 'url' => 'IT/back_pressure_₁', 'image' => '', 'title' => 'pressione residua', 'tags' => array ( 0 => 'pressione residua', 1 => 'Medical', 2 => 'Implants and interventional materials', 3 => '', ), 'term' => 'pressione residua', 'source_id' => 45591, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Medical', ), 'category' => array ( 0 => 'Implants and interventional materials', ), 'lastedit' => '20110405105859', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'pressione residua opponendo il libero flusso di un gas o un liquido', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601639329628163, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'back pressure', 'Definition' => 'residual pressure opposing the free flow of a gas or liquid', 'Domain' => 'Documentation; Marketing; Other', 'Industry' => 'Medical', 'Part of Speech' => 'noun', 'Product Category' => 'Implants and interventional materials', 'Usage Status' => 'New', 'Revision User' => 'Uwe', 'Revision Date' => '2010/6/12', 'Creation User' => 'Uwe', 'Creation Date' => '2010/6/12', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'back_pressure_₁', )

(object) array( 'id' => '958462', 'url' => 'IT/alarm_interval', 'image' => '', 'title' => 'intervallo di alarme', 'tags' => array ( 0 => 'intervallo di alarme', 1 => 'Medical', 2 => 'Implants and interventional materials', 3 => '', ), 'term' => 'intervallo di alarme', 'source_id' => 45557, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Medical', ), 'category' => array ( 0 => 'Implants and interventional materials', ), 'lastedit' => '20120917164027', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'il periodo di tempo tra ripetizione sveglia suona', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601638086017027, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'alarm interval', 'Definition' => 'the period of time between repeating alarm sounds', 'Domain' => 'Documentation; Marketing; Other', 'Industry' => 'Medical', 'Part of Speech' => 'noun', 'Product Category' => 'Implants and interventional materials', 'Usage Status' => 'New', 'Revision User' => 'Uwe', 'Revision Date' => '2010/6/12', 'Creation User' => 'Uwe', 'Creation Date' => '2010/6/12', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'alarm_interval', )

(object) array( 'id' => '958521', 'url' => 'IT/off_time', 'image' => '', 'title' => 'off time-e quando ce una funzione bassa del motore e va aumentare i sintomi di parkinson', 'tags' => array ( 0 => 'off time-e quando ce una funzione bassa del motore e va aumentare i sintomi di parkinson', 1 => 'Medical', 2 => 'Implants and interventional materials', 3 => '', ), 'term' => 'off time-e quando ce una funzione bassa del motore e va aumentare i sintomi di parkinson', 'source_id' => 45535, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Medical', ), 'category' => array ( 0 => 'Implants and interventional materials', ), 'lastedit' => '20120917164512', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Questo è quando c\'è scarsa funzione motoria e aumento dei sintomi parkinsoniani', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601638294683648, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'off time', 'Definition' => 'this is when there is poor motor function and increase in parkinsonian symptoms', 'Domain' => 'Documentation; Marketing; Other', 'Industry' => 'Medical', 'Part of Speech' => 'noun', 'Product Category' => 'Implants and interventional materials', 'Usage Status' => 'New', 'Revision User' => 'Uwe', 'Revision Date' => '2010/6/11', 'Creation User' => 'Uwe', 'Creation Date' => '2010/6/11', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'off_time', )

(object) array( 'id' => '962582', 'url' => 'IT/the_one_who', 'image' => '', 'title' => 'che/colui che/colei che', 'tags' => array ( 0 => 'che/colui che/colei che', 1 => 'Language', 2 => 'Dictionaries', 3 => 'Tagalog_English_Deutsch_twgid1297315887701002', ), 'term' => 'che/colui che/colei che', 'source_id' => 726372, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Dictionaries', ), 'lastedit' => '20110405161401', 'part_of_speech' => 'other', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'funzione Parole; articoli e pronomi; pronome dimostrativo, (deictive determinante)', 'usage_comment' => 'MT', 'glossary' => 'Tagalog_English_Deutsch_twgid1297315887701002', 'width' => 0, 'height' => 0, '_version_' => 1503601655784931329, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'the one who', 'Definition' => 'function words; articles and pronouns; demonstrative pronoun, (deictive determinative)', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Dictionaries', 'Context' => '* The woman is the one who is sick. * Ang babáe ang maysakít. * Die Frau ist diejenige, die krank ist.', 'Creation User' => 'climatepatrol', 'Creation Date' => '2011/2/11', 'Glossary' => 'Tagalog_English_Deutsch_twgid1297315887701002', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'the_one_who', )

(object) array( 'id' => '1001558', 'url' => 'IT/guillain-barre_syndrome_(GBS)', 'image' => '', 'title' => 'sindrome di Guillain-Barre\'', 'tags' => array ( 0 => 'sindrome di Guillain-Barre\'', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'sindrome di Guillain-Barre\'', 'source_id' => 392833, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408164511', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Una rara malattia neurologica caratterizzata da perdita di riflessi e paralisi temporanea. I sintomi includono debolezza, intorpidimento, formicolio e una maggiore sensibilità che si estende sopra il corpo. Paralisi del muscolo inizia nei piedi e gambe e si muove verso l\'alto per le braccia e le mani. A volte può provocare paralisi muscoli respiratori causando difficoltà respiratorie. Sintomi di solito compaiono nel corso di un giorno e possono continuare a progredire per 3 o 4 giorni fino a 3 o 4 settimane. Recupero inizia entro 2-4 settimane dopo la progressione si arresta. Mentre la maggior parte dei pazienti recupera, circa 15-20% esperienza sintomi persistenti. GBS è fatale nel 5% dei casi.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601829179555841, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'guillain-barre syndrome (GBS)', 'Definition' => 'A rare neurological disease characterized by loss of reflexes and temporary paralysis. Symptoms include weakness, numbness, tingling and increased sensitivity that spreads over the body. Muscle paralysis starts in the feet and legs and moves upwards to the arms and hands. Sometimes paralysis can result in the respiratory muscles causing breathing difficulties. Symptoms usually appear over the course of one day and may continue to progress for 3 or 4 days up to 3 or 4 weeks. Recovery begins within 2-4 weeks after the progression stops. While most patients recover, approximately 15%-20% experience persistent symptoms. GBS is fatal in 5% of cases.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'guillain-barre_syndrome_(GBS)', )

(object) array( 'id' => '962324', 'url' => 'IT/agglutinative_language', 'image' => '', 'title' => 'lingua agglutinativa', 'tags' => array ( 0 => 'lingua agglutinativa', 1 => 'Language', 2 => 'Grammar', 3 => '', ), 'term' => 'lingua agglutinativa', 'source_id' => 791753, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Grammar', ), 'lastedit' => '20120718184024', 'part_of_speech' => 'adjective', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Lingue agglutinanti (o UAI) sono quelli che spesso combinano i loro steli con molti affissi per formare parole lunghe.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601654857990144, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'agglutinative language', 'Definition' => 'Agglutinative (or agglutinating) languages are those which often combine their stems with many affixes to form long words.', 'Domain' => 'Documentation', 'Industry' => 'Language', 'Part of Speech' => 'adjective', 'Product Category' => 'Grammar', 'Usage Status' => 'New', 'Creation User' => 'CarmenChavarri', 'Creation Date' => '2011/2/23', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'agglutinative_language', )

(object) array( 'id' => '997249', 'url' => 'IT/investigational_vaccine', 'image' => '', 'title' => 'vaccino investigativo (Il termine “investigativo” significa che il vaccino è stato approvato dalle appropriate autorità regolatorie per utilizzo in studi clinici, ma non è stato approvato ancora per uso di routine)', 'tags' => array ( 0 => 'vaccino investigativo (Il termine “investigativo” significa che il vaccino è stato approvato dalle appropriate autorità regolatorie per utilizzo in studi clinici, ma non è stato approvato ancora per uso di routine)', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'vaccino investigativo (Il termine “investigativo” significa che il vaccino è stato approvato dalle appropriate autorità regolatorie per utilizzo in studi clinici, ma non è stato approvato ancora per uso di routine)', 'source_id' => 392703, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408113528', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Un vaccino che è stato approvato dalla Food and Drug Administration (FDA) per l\'utilizzo in studi clinici sull\'uomo. Tuttavia, in fase di sperimentazione vaccini sono ancora in fase di test e valutazione e non sono concessi in licenza per l\'utilizzo in pubblico.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601809291214850, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'investigational vaccine', 'Definition' => 'A vaccine that has been approved by the Food and Drug Administration (FDA) for use in clinical trials on humans. However, investigational vaccines are still in the testing and evaluation phase and are not licensed for use in the general public.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'investigational_vaccine', )

(object) array( 'id' => '969843', 'url' => 'IT/Herceptin', 'image' => '', 'title' => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 'tags' => array ( 0 => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 'source_id' => 31147, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110406090141', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'un nome di marchio per Trastuzumab, che è un farmaco per il cancro al seno', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601687079682048, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'Herceptin', 'Definition' => 'a trademark name for Trastuzumab, which is a breast cancer drug', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Herceptin', )

(object) array( 'id' => '958802', 'url' => 'IT/bifurcated_extension', 'image' => '', 'title' => 'estensione biforcata', 'tags' => array ( 0 => 'estensione biforcata', 1 => 'Medical', 2 => 'Implants and interventional materials', 3 => '', ), 'term' => 'estensione biforcata', 'source_id' => 45651, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Medical', ), 'category' => array ( 0 => 'Implants and interventional materials', ), 'lastedit' => '20110405110551', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'un\'estensione con due conduttori', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601639487963137, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'bifurcated extension', 'Definition' => 'an extension with two leads', 'Domain' => 'Documentation; Marketing; Other', 'Industry' => 'Medical', 'Part of Speech' => 'noun', 'Product Category' => 'Implants and interventional materials', 'Usage Status' => 'New', 'Revision User' => 'Uwe', 'Revision Date' => '2010/6/12', 'Creation User' => 'Uwe', 'Creation Date' => '2010/6/12', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'bifurcated_extension', )